COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Dental Intervention Group: mucoadhesive slow-release paste mucodentol (carvacrol 3%) produced in Khorraman Pharmaceutical Company located in Khorramabad has been recommended to use it
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age over 18 years old Mental and physical ability to use this drug for three weeks Lack of sensitivity to drugs and similar drugs People are aware of time, place person, are mentally and emotionally normal be able to communicate verbally for telephone interviews Infected to covid-19
Exclusion criteria
Exclusion criteria: Lack of cooperation Do not use the drug regularly Having corona and need to be hospitalized Drug sensitivity Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The symptoms caused by the Covid-19. Timepoint: Three times a day before bed. Method of measurement: In case of home quarantine, since it is advisable for personal protection, people should not leave the house. At the end of the first week, Second and third week, the desired symptoms will be asked and recorded as a telephone interview. In case of hospitalization, patients will be interviewed and examined. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: daily. Method of measurement: Thermometer.;Respiratory-general symptoms. Timepoint: daily. Method of measurement: yes/no. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehrooz Farzan
Khoram-Abad University of Medical Sciences
Outcome results
None listed